Just watched the Sequire presentation.  It provides more detail on activities over next 2-3 years.  Covid Ph2 and Ph3 (USA) results within next few months and next year.  If successful this 'may' boost SP enough to address the June 2023 warrant deadline.(?) BoM2 interim results mid to late 2023 ...... but it seems these things tend to take longer than planned.  Anyway, if you're a believer the current SP looks attractive and funding for these trials seems to be (more or less) getting resolved.